What did @itvnews actually say?
The report made two headline claims: Amazon was selling peptides labeled "not fit for human consumption" in packaging that looked like ordinary supplements, and independent lab testing found "no trace of the advertised peptide BPC-157" in any of the tablets purchased. A secondary claim put counterfeiting rates at "around half of all performance-enhancing drugs." That last figure is worth scrutinizing, but the core finding is specific and testable.
The reporter also noted that obtaining these substances has shifted from black-market gym culture to mainstream e-commerce. That shift is real, and it matters for consumer safety in ways the video only partially explores. Amazon removed the product after the report, which the creator mentions, but the platform's broader enforcement problem goes unaddressed.
Does the science back this up?
The adulteration finding is plausible and consistent with published research. Yes, this kind of thing happens regularly in the unregulated supplement and research-chemical space.
A 2018 study by Cohen et al. in JAMA Internal Medicine found that a significant proportion of supplements sold through major online retailers contained undisclosed or mislabeled ingredients. More specifically to peptides, a 2021 analysis by Thevis et al. in Drug Testing and Analysis examined research-grade peptide products and found labeling inaccuracies and contamination were common. BPC-157 in oral tablet form is particularly suspect because the peptide is poorly absorbed orally in most studied formulations, meaning even a genuine product has questionable bioavailability. The University of Sunderland testing methodology isn't detailed in the video, so we can't assess sensitivity thresholds, but the result, zero detected peptide, is a hard finding.
The "half of all performance-enhancing drugs are counterfeit" figure appears to trace back to estimates from anti-doping researchers, but the sourcing in the video is vague. It may be accurate for specific markets at specific times, but presenting it as a settled global statistic overstates the certainty.
What did they get wrong (or right)?
They got the core finding right. A product labeled BPC-157 contained no detectable BPC-157. That is straightforward fraud, and naming Amazon as the retailer is fair and accurate reporting.
Where the video falls short is context. Framing all peptides as equivalent to black-market drugs is reductive. Peptides like BPC-157 and TB-500 exist in legitimate research settings, and some are being investigated in clinical trials. The video conflates research chemicals, fraudulent supplements, and regulated therapeutics into one undifferentiated category of dangerous internet drugs. That framing may alarm viewers without helping them understand the actual regulatory distinction between a research-use peptide and a fraudulent oral tablet with no active ingredient.
The report also skips the bigger question: why do buyers end up on Amazon in the first place? Lack of accessible, regulated telehealth pathways pushes people toward unvetted retail channels. That context would have made the story more useful.
What should you actually know?
The practical takeaway here is about sourcing, not about peptides being inherently dangerous or fake. Products sold as research chemicals or supplements are not subject to pharmaceutical-grade manufacturing standards. That means no guaranteed potency, no verified purity, and no third-party certificate of analysis that carries legal accountability.
BPC-157 in oral tablet form has weak pharmacokinetic support regardless of purity. Most research on BPC-157 uses injectable or subcutaneous administration. A tablet containing zero peptide is obviously worthless, but even a genuine oral BPC-157 tablet would face absorption questions not yet resolved in peer-reviewed human trials.
- Always request a certificate of analysis from an accredited lab before using any peptide product.
- "Research purposes only" labeling is a legal disclaimer, not a quality guarantee.
- Regulated telehealth platforms operate under different standards than retail supplement sellers or Amazon marketplace vendors.
- If a product's packaging looks like a consumer supplement but carries a research-use disclaimer, that is a regulatory gray zone, not safety validation.